(Q90672936)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32215341%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

case report

0 references

title

Serum KL-6 elevation in a uveitis patient with Behçet's disease treated with adalimumab (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32215341%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

1 reference

1 reference

1 reference

Takashi Ono

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32215341%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

Takuya Iwasaki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32215341%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

Yukiko Terada

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32215341%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

Kentaro Abe

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32215341%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

Jinhee Lee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32215341%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

Manabu Mochizuki

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32215341%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

Kazunori Miyata

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32215341%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

publication date

13 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32215341%20AND%20SRC:MED&resulttype=core&format=json

American journal of ophthalmology case reports

15 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32215341%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32215341%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

page(s)

100660

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32215341%20AND%20SRC:MED&resulttype=core&format=json

Behçet disease (Behçet syndrome)

15 April 2020

cites work

1 reference

12 December 2020

Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

1 reference

12 December 2020

Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases.

1 reference

12 December 2020

Adalimumab for sight-threatening uveitis in Behçet's disease.

1 reference

12 December 2020

KL-6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis

1 reference

12 December 2020

The use of biologic agents in the treatment of ocular manifestations of Behcet's disease

1 reference

12 December 2020

Serum KL-6 level as an indicator of active or inactive interstitial pneumonitis associated with connective tissue diseases.

1 reference

12 December 2020

Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases

1 reference

12 December 2020

A retrospective study of serum KL-6 levels during treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients: a report from the Ad Hoc Committee for Safety of Biological DMARDs of the Japan College of Rheumatolo

1 reference

12 December 2020

Elevation of KL-6 serum levels in clinical trials of tumor necrosis factor inhibitors in patients with rheumatoid arthritis: a report from the Japan College of Rheumatology Ad Hoc Committee for Safety of Biological DMARDs

1 reference

12 December 2020

Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders

1 reference

12 December 2020

Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study.

1 reference

12 December 2020

Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis

1 reference

12 December 2020

Serum KL-6 elevation and possible pulmonary involvement in patients with rheumatoid arthritis treated with biological agents.

1 reference

12 December 2020

Infliximab and adalimumab, unlike ustekinumab, increase serum KL-6 levels in Japanese patients with psoriasis

1 reference

12 December 2020

Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study

1 reference

12 December 2020

Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial

1 reference

12 December 2020

Impact of anti-tumor necrosis factor-α agents on serum levels of KL-6 and surfactant protein-D in patients with psoriasis.

1 reference

12 December 2020

Cataract Surgery Complications in Uveitis Patients: A Review Article.

1 reference

12 December 2020

Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III.

1 reference

12 December 2020

10.1016/J.AJOC.2020.100660

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32215341%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32215341%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

1 reference